| P50 | author | Kjeld Søballe | Q41603042 |
| | Chao Xie | Q42831991 |
| P2093 | author name string | Regis J O'Keefe | |
| | Jie Li | |
| | Dan Li | |
| | Steven T Proulx | |
| | Kirill Gromov | |
| | Edward M Schwarz | |
| | Lianping Xing | |
| | Hani A Awad | |
| | Daniel P Crane | |
| P2860 | cites work | Systemic tumor necrosis factor alpha mediates an increase in peripheral CD11bhigh osteoclast precursors in tumor necrosis factor alpha-transgenic mice | Q44733643 |
| | Chronic diffuse sclerosing osteomyelitis treated with risedronate | Q46581935 |
| | Arthritis induces lymphocytic bone marrow inflammation and endosteal bone formation | Q47654090 |
| | Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL. | Q50335960 |
| | Lymphedema therapy reduces the volume of edema and pain in patients with breast cancer. | Q51054001 |
| | Osteonecrosis of the jaws in patients treated with bisphosphonates - histomorphologic analysis in comparison with infected osteoradionecrosis. | Q51820659 |
| | Patients with bisphosphonates-associated osteonecrosis of the jaw have reduced circulating endothelial cells. | Q53545693 |
| | Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research | Q58216587 |
| | Quantitative small-animal surrogate to evaluate drug efficacy in preventing wear debris-induced osteolysis | Q73472299 |
| | Osteonecrosis of the jaw: more research needed | Q80331532 |
| | MRI and quantification of draining lymph node function in inflammatory arthritis | Q80656000 |
| | A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function | Q24336057 |
| | RANK is essential for osteoclast and lymph node development | Q24598872 |
| | Osteoclasts: what do they do and how do they do it? | Q24683898 |
| | Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment | Q28278528 |
| | OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 |
| | Invasive methicillin-resistant Staphylococcus aureus infections in the United States | Q29616087 |
| | Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice | Q29622922 |
| | Direct three-dimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus. | Q30579244 |
| | Osteomyelitis | Q33205211 |
| | Therapeutic approaches to bone diseases | Q34021178 |
| | Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy. | Q34345061 |
| | Treatment of infections associated with surgical implants | Q35740678 |
| | Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases | Q35762495 |
| | Clinical development of anti-RANKL therapy | Q35901092 |
| | Periosteal progenitor cell fate in segmental cortical bone graft transplantations: implications for functional tissue engineering | Q35924333 |
| | Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases | Q36005131 |
| | Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century? | Q36122038 |
| | TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation | Q36368029 |
| | The management of peri-prosthetic infection in total joint arthroplasty. | Q36376709 |
| | Bisphosphonates and osteonecrosis of the jaws: science and rationale | Q36797579 |
| | Osteonecrosis of the jaw related to the use of bisphosphonates. | Q36838957 |
| | Bisphosphonate-related osteonecrosis of the jaws: a comprehensive review | Q36845212 |
| | Longitudinal assessment of synovial, lymph node, and bone volumes in inflammatory arthritis in mice by in vivo magnetic resonance imaging and microfocal computed tomography. | Q37143025 |
| | Quantitative mouse model of implant-associated osteomyelitis and the kinetics of microbial growth, osteolysis, and humoral immunity | Q37239935 |
| | Monitoring bioluminescent Staphylococcus aureus infections in living mice using a novel luxABCDE construct | Q39516464 |
| | VEGF-C, a lymphatic growth factor, is a RANKL target gene in osteoclasts that enhances osteoclastic bone resorption through an autocrine mechanism | Q39647223 |
| | Pamidronate in the treatment of diffuse sclerosing osteomyelitis of the mandible | Q43820573 |
| | Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic | Q43968160 |
| | Regulatory effects of osteoprotegerin on cellular and humoral immune responses | Q44707640 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | osteomyelitis | Q938983 |
| P304 | page(s) | 84-94 | |
| P577 | publication date | 2010-03-01 | |
| P1433 | published in | Annals of the New York Academy of Sciences | Q2431664 |
| P1476 | title | Effects of antiresorptive agents on osteomyelitis: novel insights into the pathogenesis of osteonecrosis of the jaw. | |
| P478 | volume | 1192 | |